General Information of Drug Transporter (DT)
DT ID DTD0277 Transporter Info
Gene Name SLC30A9
Transporter Name Zinc transporter 9
Gene ID
10463
UniProt ID
Q6PML9
Post-Translational Modification of This DT
Overview of SLC30A9 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Malonylation X-Oxidation X-Phosphorylation X: Amino Acid

Malonylation

  Lysine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC30A9 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

374

Experimental Method

Co-Immunoprecipitation

Detailed Description

Malonylation at SLC30A9 Lysine 374 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC30A9 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

479

Experimental Method

Co-Immunoprecipitation

Detailed Description

Malonylation at SLC30A9 Lysine 479 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC30A9 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

487

Experimental Method

Co-Immunoprecipitation

Detailed Description

Malonylation at SLC30A9 Lysine 487 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC30A9 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

141

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC30A9 Cystine 141 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC30A9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

88

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A9 Serine 88 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC30A9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

183

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A9 Serine 183 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC30A9 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

303

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A9 Serine 303 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC30A9 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

471

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A9 Serine 471 has the potential to affect its expression or activity.
References
1 Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
4 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.